Managed Asset Portfolios sold 120,214 shares of ECG in the fourth quarter; the estimated transaction value was $10.76 million based on average fourth-quarter prices.
Meanwhile, the quarter-end position value decreased by $10.34 million, reflecting both share reduction and price changes.
After the transaction, the fund reported holding 149,465 ECG shares valued at $12.79 million.
On January 29, Managed Asset Portfolios disclosed a sale of 120,214 shares of Everus Construction Group (NYSE:ECG), an estimated $10.76 million trade based on quarterly average pricing.
According to an SEC filing dated January 29, Managed Asset Portfolios reduced its position in Everus Construction Group by 120,214 shares during the fourth quarter. The estimated value of shares sold was $10.76 million, calculated using the average closing price over the quarter. At quarter-end, the ECG position was valued at $12.79 million, with the net position change reflecting a $10.34 million decrease after accounting for price movement.
The trade lowered the ECG holding to 1.54% of the fund’s 13F reportable assets, down from 2.9% in the prior quarter.
Top holdings after the filing:
As of January 28, shares of ECG were priced at $93.75, up 37.9% over the prior year and well outperforming the S&P 500 by 22.89 percentage points.
| Metric | Value |
|---|---|
| Revenue (TTM) | $3.49 billion |
| Net income (TTM) | $180.96 million |
| Price (as of 1/28/26) | $93.75 |
| One-year price change | 37.89% |
Everus Construction Group, Inc. operates at scale in the engineering and construction sector, with a diversified portfolio spanning utility infrastructure and specialty services. The company's integrated business model combines construction expertise with equipment manufacturing and ongoing service contracts, supporting recurring revenue streams. Strategic focus on utility and commercial markets positions Everus to capitalize on infrastructure investment and regulatory-driven demand.
Everus just delivered a strong third quarter, with revenue up nearly 30% year over year, EBITDA jumping 37%, and backlog climbing to roughly $2.95 billion. Management raised full-year 2025 guidance again, now calling for up to $3.65 billion in revenue and as much as $300 million in EBITDA.
Against that backdrop, this sale looks less like a loss of conviction and more like risk management. The stock is up nearly 38% over the past year, very sharply outperforming the broader market. Trimming exposure after that kind of run can free up capital without abandoning the underlying thesis.
It also fits the fund’s broader posture. The portfolio leans toward diversified income and mega-cap exposure, suggesting a preference for balancing cyclical infrastructure bets with steadier allocations. Ultimately, Everus remains financially strong, with low leverage and rising free cash flow, but concentration cuts after outsized gains are often a feature of disciplined portfolio construction.
When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor’s total average return is 950%* — a market-crushing outperformance compared to 197% for the S&P 500.
They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor.
See the stocks »
*Stock Advisor returns as of January 29, 2026.
Jonathan Ponciano has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Alphabet, Cisco Systems, and Microsoft. The Motley Fool has a disclosure policy.